Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma news

    Tag: pharma news

    You Searched For "pharma news"
    Sanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of US

    Sanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of US

    Farhat Nasim2 May 2019 10:00 AM IST
    Dengvaxia is a live, attenuated vaccine that is administered as three separate injections, with the initial dose followed by two additional shots...
    AstraZeneca ties up with Transgene to develop viral immunotherapies

    AstraZeneca ties up with Transgene to develop viral immunotherapies

    Garima2 May 2019 9:25 AM IST
    AstraZeneca has been moving deeper into cancer therapy market through wide-ranging deals, including those for immunotherapy and targeted therapy.New...
    Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen

    Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen

    Meghna A Singhania30 April 2019 10:16 AM IST
    Glenmark will commercialize Remogliflozin in India under the brand names 'Remo' and 'Remozen'.Mumbai: In a major relief to diabetics, Glenmark...
    CDSCO approves Zydus, SIFI pact to launch Intraocular Lenses in India

    CDSCO approves Zydus, SIFI pact to launch Intraocular Lenses in India

    Farhat Nasim30 April 2019 10:15 AM IST
    "SIFI's innovative IOLs (Intraocular lenses) have been approved by the Indian Central Drugs Standards Control Organisation(CDSCO) (Directorate General...
    Cipla gets USFDA nod for Ambrisentan tablets to treat pulmonary arterial hypertension

    Cipla gets USFDA nod for Ambrisentan tablets to treat pulmonary arterial hypertension

    Farhat Nasim30 April 2019 10:00 AM IST
    Cipla's Ambrisentan tablets 5 mg and 10 mg is AB-rated generic therapeutic equivalent version of Gilead Sciences Inc's Letairis.New Delhi: Drug major...
    GSK gets USFDA nod for Benlysta to treat pediatric patients with lupus

    GSK gets USFDA nod for Benlysta to treat pediatric patients with lupus

    Medical Dialogues Bureau30 April 2019 9:15 AM IST
    New Delhi: GlaxoSmithKline (GSK) has won the US Food and Drug Administration's (USFDA) approval for its Benlysta (belimumab) intravenous (IV) infusion...
    Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer

    Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer

    Farhat Nasim29 April 2019 9:35 AM IST
    The positive CHMP opinion of TALZENNA follows the medicine's approval by the U.S. Food and Drug Administration (FDA) in October 2018.New Delhi:...
    Roche withdraws refiling of Premerger Notification, Report Form under the HSR Act

    Roche withdraws refiling of Premerger Notification, Report Form under the HSR Act

    Farhat Nasim28 April 2019 9:45 AM IST
    Roche has elected to withdraw and refile the Premerger Notification and Report Form under the HSR Act.New Delhi: Roche and Spark Therapeutics, Inc....
    Sun Pharma gets 11 USFDA observations for Dadra plant, BSE asks for response: Report

    Sun Pharma gets 11 USFDA observations for Dadra plant, BSE asks for response: Report

    Farhat Nasim26 April 2019 2:20 PM IST
    New Delhi: Sun Pharmaceutical (Sun Pharma) Industries Ltd's Dadra plant has reportedly received 11 observations, "serious" in nature from the U.S....
    Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis

    Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis

    Farhat Nasim26 April 2019 12:49 PM IST
    Leflunomide tablet is used to treat rheumatoid arthritis, a condition affecting multiple small and large joints of the body.New Delhi: Drug firm Zydus...
    Glenmark Pharma gets USFDA approval for generic version of VAGIFEM

    Glenmark Pharma gets USFDA approval for generic version of VAGIFEM

    Farhat Nasim25 April 2019 10:50 AM IST
    The approved product Estradiol Vaginal Inserts USP, 10 mcg is a generic version of Novo Nordisk Inc's VAGIFEM. New Delhi: Glenmark Pharmaceuticals has...
    Indoco Remedies: USFDA retains OAI status for Goa plant

    Indoco Remedies: USFDA retains OAI status for Goa plant

    Farhat Nasim25 April 2019 9:50 AM IST
    Indoco Remedies' spokesperson said that the move is likely to withhold approval of pending abbreviated new drug applications (ANDAs) from Goa...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok